Table 3. Metabolic co-expression variables in cancer and stromal cells as predictors of disease-specific survival in 335 NSCLC patients (univariate analyses; log-rank test).
Co-expression variables | Patients N (%) | Median survival (months) | 5-year survival (%) | P |
GLUT1c+MCT1s | .001 | |||
Low/Low | 25 | NR | 91 | |
Other | 114 | 190 | 63 | |
High/High | 161 | 64 | 51 | |
Missing | 35 | |||
GLUT1c+MCT4c | .003 | |||
Low/Low | 31 | NR | 82 | |
Other | 170 | 190 | 62 | |
High/High | 101 | 52 | 48 | |
Missing | 33 | |||
MCT4c+MCT1s | .009 | |||
Low/Low | 72 | NR | 74 | |
Other | 129 | 98 | 58 | |
High/High | 97 | 57 | 50 | |
Missing | 37 | |||
MCT1c+MCT4s | .006 | |||
Low/Low | 81 | 62 | 51 | |
Other | 114 | 62 | 51 | |
High/High | 106 | NR | 72 | |
Missing | 34 |